| Margaret F Guill, MD | |
|
1 Medical Center Dr, Dhmc Department Of Pediatrics, Lebanon, NH 03756-1000 | |
| (603) 653-9884 | |
| (603) 650-0907 |
| Full Name | Margaret F Guill |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Pulmonology |
| Location | 1 Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306956750 | NPI | - | NPPES |
| 30208783 | Medicaid | NH | |
| 460538 | Medicaid | SC | |
| 1016449 | Medicaid | VT | |
| 000210306A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0214X | Pediatrics - Pediatric Pulmonology | 016533 (Georgia) | Secondary |
| 2080P0214X | Pediatrics - Pediatric Pulmonology | 14380 (New Hampshire) | Primary |
| Entity Name | Au Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841230620 PECOS PAC ID: 9931013513 Enrollment ID: O20040107000188 |
News Archive
Taking a minute or two every day to inspect your feet and observing a few simple rules can make the difference in sparing diabetes patients from a preventable outcome of the disease a foot amputation.
Icotinib has been found to be noninferior to gefitinib in patients with non-small-cell lung cancer, according to reports from the phase III Chinese double-blind ICOGEN study.
Dr. Barry Reiner announced that he is now recruiting children and adults with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protege, has completed enrollment of more than 530 subjects with type 1 diabetes. There is currently no approved therapy to slow the progression of type 1 diabetes.
A new study that compared HIV-positive women over 50 years of age with their younger HIV-infected cohorts found that while the older women were less likely to be sexually active and to report condomless sex with a male partner, those who were sexually active were not as likely to undergo screening for gonorrhea, chlamydia, or syphilis than their younger counterparts.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has conducted further evaluation of the patent infringement lawsuit filed against the company last week by Cook Medical, and of the patents asserted in the lawsuit.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Margaret F Guill, MD 1 Medical Center Dr, Dhmc Department Of Pediatrics, Lebanon, NH 03756-1000 Ph: (603) 653-9884 | Margaret F Guill, MD 1 Medical Center Dr, Dhmc Department Of Pediatrics, Lebanon, NH 03756-1000 Ph: (603) 653-9884 |
News Archive
Taking a minute or two every day to inspect your feet and observing a few simple rules can make the difference in sparing diabetes patients from a preventable outcome of the disease a foot amputation.
Icotinib has been found to be noninferior to gefitinib in patients with non-small-cell lung cancer, according to reports from the phase III Chinese double-blind ICOGEN study.
Dr. Barry Reiner announced that he is now recruiting children and adults with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protege, has completed enrollment of more than 530 subjects with type 1 diabetes. There is currently no approved therapy to slow the progression of type 1 diabetes.
A new study that compared HIV-positive women over 50 years of age with their younger HIV-infected cohorts found that while the older women were less likely to be sexually active and to report condomless sex with a male partner, those who were sexually active were not as likely to undergo screening for gonorrhea, chlamydia, or syphilis than their younger counterparts.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has conducted further evaluation of the patent infringement lawsuit filed against the company last week by Cook Medical, and of the patents asserted in the lawsuit.
› Verified 4 days ago
Sheila L Feyrer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5 Alice Peck Day Dr, Lebanon, NH 03766 Phone: 603-448-3122 Fax: 603-448-7491 | |
Scott Shipman, MD, MPH Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-653-9337 | |
Dr. Julie Lucy Sanville, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: One Medical Center Drive, Gastroenterology, Lebanon, NH 03756 Phone: 603-653-9666 Fax: 603-653-9166 | |
Dr. Torunn Thorsen Rhodes, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-653-6063 | |
Kimberly Molina, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Dr. Tricia Lynn Groff, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Dhmc Department Of Pediatrics, Lebanon, NH 03756 Phone: 603-653-9663 | |
Paul Eric Palumbo, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Infectious Disease - Dartmouth-hitchcock Med Ctr, Lebanon, NH 03756 Phone: 603-650-8840 Fax: 603-650-6199 |